Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both-Reference-Cited by-同舟云学术

Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both

Published:2016-04-01 Issue:4 Volume:2 Page:493
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

James Nicholas D.¹,Pirrie Sarah J.²,Pope Ann M.²,Barton Darren²,Andronis Lazaros³,Goranitis Ilias³,Collins Stuart⁴,Daunton Adam¹,McLaren Duncan⁵,O’Sullivan Joe⁶,Parker Christopher⁷,Porfiri Emilio¹,Staffurth John⁸,Stanley Andrew⁹,Wylie James¹⁰,Beesley Sharon¹¹,Birtle Alison¹²,Brown Janet¹³,Chakraborti Prabir¹⁴,Hussain Syed¹⁵,Russell Martin¹⁶,Billingham Lucinda J.²

Affiliation:

1. University Hospital Birmingham NHS Foundation Trust, Birmingham, England

2. Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, England

3. Health Economics Unit, University of Birmingham, England

4. Cancer Research UK Clinical Trials Unit, Birmingham, England

5. Department of Clinical Oncology, Western General Hospital, Edinburgh, Scotland

6. Northern Ireland Cancer Centre, Belfast City Hospital, Belfast, Northern Ireland

7. The Institute of Cancer Research & Royal Marsden NHS Foundation Trust, Sutton, England

8. Institute of Cancer and Genetics, Cardiff University, Cardiff, Wales

9. Department of Oncology Pharmacy, Birmingham City Hospital, Birmingham, England

10. Department of Clinical Oncology, The Christie Hospital, Manchester, England

11. Department of Clinical Oncology, Kent Oncology Centre, Maidstone, England

12. Rosemere Cancer Centre, Royal Preston Hospital, Lancashire, England

13. Cancer Research UK Clinical Centre at Leeds, University of Leeds, St James’ University Hospital, Leeds, England

14. Department of Oncology, Royal Derby Hospital, Derby, England

15. Institute of Translational Medicine, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, England

16. Beatson West of Scotland Cancer Centre, Glasgow, Scotland

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Radiopharmaceutical Therapy for Bone Metastases;Seminars in Nuclear Medicine;2024-07

2. Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?;Journal of Nuclear Medicine;2024-04-11

3. Advancements in the development of radiopharmaceuticals for nuclear medicine applications in the treatment of bone metastases;Nuclear Medicine and Biology;2024-03

4. Novel Therapeutic Targets on the Horizon: An Analysis of Clinical Trials on Therapies for Bone Metastasis in Prostate Cancer;Cancers;2024-01-31

5. FOXA1-dependent PUS1 regulates EIF3b stability in a non-enzymatic pathway mediating prostate cancer bone metastasis;International Journal of Biological Sciences;2024